REMUS · Ratios · TradingHolo

Markets › India › NSE › REMUS

Remus Pharmaceuticals Ltd

NSE:REMUSHealthcare

₹984.50−1.75%At closeAt close · Mon 19 Oct · ≈ AED 38.04 · Market cap $124.22M

🔔 Alert▶ Test a strategy

Ratio	FY2020	FY2021	FY2022	FY2023	FY2024	FY2025	Trend	YoY
Gross margin	20.4%	32.0%	37.0%	18.7%	11.4%	11.0%		−0.4 pts
Operating margin	4.2%	17.1%	23.5%	13.1%	7.1%	6.4%		−0.7 pts
Net margin	5.6%	13.9%	18.9%	9.6%	4.7%	4.3%		−0.4 pts
EBITDA margin	5.1%	17.7%	24.6%	13.7%	7.4%	6.7%		−0.7 pts
Return on equity	33.7%	52.2%	44.4%	13.0%	11.4%	10.5%		−0.8 pts
Return on assets	9.3%	21.7%	24.5%	6.2%	6.7%	6.4%		−0.3 pts
Return on capital employed	23.0%	63.3%	39.9%	14.6%	14.2%	12.6%		−1.5 pts
Debt / equity	0.1×	0.0×	0.4×	0.1×	0.1×	0.1×		−14.1%
Debt / assets	2.5%	1.2%	22.9%	4.3%	5.3%	4.7%		−0.6 pts
Interest coverage	23.3×	135.4×	96.2×	55.9×	30.2×	37.0×		+22.4%
Current ratio	1.0×	0.8×	1.4×	1.5×	1.8×	2.0×		+8.5%
Quick ratio	0.8×	0.6×	1.2×	1.2×	1.4×	1.5×		+5.6%
Cash ratio	0.1×	0.1×	0.4×	0.1×	0.1×	0.1×		+29.0%
Asset turnover	1.7×	1.6×	1.3×	0.6×	1.4×	1.5×		+2.9%
Inventory turnover	10.7×	8.3×	22.7×	3.9×	10.4×	10.0×		−4.4%
Receivables turnover	5.1×	8.2×	9.1×	1.5×	4.6×	5.7×		+25.2%
Dividend payout	0.0%	0.0%	0.0%	2.9%	4.1%	3.2%		−0.9 pts

Margins, returns, leverage and liquidityUpdated Tue 31 Mar ·

ⓘ